Hepatitis D - Epidemiology Forecast to 2027

Hepatitis D - Epidemiology Forecast to 2027

Category

Pharmaceuticals

Published Date

1st Apr 2018

Pages

Choose License

Final Price

‘Hepatitis D - Epidemiology Forecast to 2027’ report delivers an in-depth understanding of the disease, historical & forecasted epidemiology of Hepatitis D in the United States, EU5 (Germany, Spain, Italy, France and United Kingdom), Japan and China.

Geography Covered
• The United States
• EU5 (Germany, France, Italy, Spain and the United Kingdom)
• Japan
• China

Study Period: 2016-2027

Hepatitis D Epidemiology
The Hepatitis D epidemiology division provide the insights about historical and current patient pool and forecasted trend for each of the 8 major countries. The epidemiology data for Hepatitis D are studied through all possible division to give a better understanding about the Disease scenario in 8MM. It also helps to recognize the causes of current and forecasted trends by exploring numerous studies, survey reports and views of key opinion leaders.

Hepatitis D Epidemiology Segmentation
The disease epidemiology covered in the report provides historical as well as forecasted epidemiology [total prevalent cases, prevalence by Severity (Fulminant, Acute & Chronic), Gender Specific prevalence, Age Specific prevalence and diagnosed cases] of Hepatitis D in the 8MM covering United States, EU5 countries (Germany, Spain, Italy, France and United Kingdom), Japan and China from 2016-2027.
This report also provides the epidemiology trends observed in the 8MM during the study period, along with the assumptions undertaken. The calculated data are presented with relevant tables and graphs to give a clear view of the epidemiology at first sight.
According to this report, total prevalent population of Hepatitis D in 8 major markets was estimated to be 10,546,938 in 2016.

Report Scope
• The report covers detailed overview of Hepatitis D explaining its causes, symptoms, classification, pathophysiology, diagnosis and treatment patterns
• The report provides the insight about the historical and forecasted patient pool of Hepatitis D in 8 major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK), Japan and China.
• The Report assesses the disease risk and burden and highlights the unmet needs of the disease
• The Report helps to recognize the growth opportunities in the 8MM with respect to the patient population
• The report provides the segmentation of the disease epidemiology by severity (Fulminant, Acute & Chronic), Gender-Specific, Age-specific and diagnosed prevalent cases of Hepatitis D

Key strengths
• 10 Year Forecast of Hepatitis D epidemiology
• 8MM Coverage
• Diagnosed Prevalent cases of Hepatitis D
• Prevalent Cases according to segmentation: by severity (Fulminant, Acute & Chronic), Gender-Specific, Age-specific and diagnosed prevalent cases of Hepatitis D in 8MM

Key assessments
• Patient Segmentation
• Disease Risk & Burden
• Risk of disease by the segmentation
• Factors driving growth in a specific patient population
1. Key Insights
2. Disease Background and Overview: Hepatitis D
2.1. Introduction
2.2. Classification
2.3. Factors influencing Hepatitis D Progression
2.4. Disease Causes
2.5. HDV-Symptoms
2.6. Pathogenesis
2.7. Pathophysiology
2.8. HDV Diagnosis
2.9. Prevention
3. Epidemiology and Patient Population
3.1. Key Findings
3.2. 8MM Prevalent Population of Hepatitis D
4. Country Wise-Epidemiology of Hepatitis D
4.1. United States
4.1.1. Prevalent cases of Hepatitis D in the United States
4.1.2. Prevalent Population of Hepatitis D by severity
4.1.3. Gender Specific Hepatitis D Prevalence
4.1.4. Age Specific Hepatitis D Prevalence
4.1.5. Diagnosed cases of Chronic Hepatitis D
4.2. EU5
4.2.1. Prevalent Population of Hepatitis D in EU5
4.3. France
4.3.1. Prevalent Population of Hepatitis D
4.3.2. Prevalent Population of Hepatitis D by severity
4.3.3. Gender Specific Hepatitis D Prevalence
4.3.4. Age Specific Hepatitis D Prevalence
4.3.5. Diagnosed cases of Chronic Hepatitis D
4.4. Germany
4.4.1. Prevalent Population of Hepatitis D
4.4.2. Prevalent Population of Hepatitis D by severity
4.4.3. Gender Specific Hepatitis D Prevalence
4.4.4. Age Specific Hepatitis D Prevalence
4.4.5. Diagnosed cases of Chronic Hepatitis D
4.5. Italy
4.5.1. Prevalent Population of Hepatitis D
4.5.2. Prevalent Population of Hepatitis D by severity
4.5.3. Gender Specific Hepatitis D Prevalence
4.5.4. Age Specific Hepatitis D Prevalence
4.5.5. Diagnosed cases of Chronic Hepatitis D
4.6. Spain
4.6.1. Prevalent Population of Hepatitis D
4.6.2. Prevalent Population of Hepatitis D by severity
4.6.3. Gender Specific Hepatitis D Prevalence
4.6.4. Age Specific Hepatitis D Prevalence
4.6.5. Diagnosed cases of Chronic Hepatitis D
4.7. United Kingdom
4.7.1. Prevalent Population of Hepatitis D
4.7.2. Prevalent Population of Hepatitis D by severity
4.7.3. Gender Specific Hepatitis D Prevalence
4.7.4. Age Specific Hepatitis D Prevalence
4.7.5. Diagnosed cases of Chronic Hepatitis D
4.8. Japan
4.8.1. Prevalent Population of Hepatitis D
4.8.2. Prevalent Population of Hepatitis D by severity
4.8.3. Gender Specific Hepatitis D Prevalence
4.8.4. Age Specific Hepatitis D Prevalence
4.8.5. Diagnosed cases of Chronic Hepatitis D
4.9. China
4.9.1. Prevalent Population of Hepatitis D
4.9.2. Prevalent Population of Hepatitis D by severity
4.9.3. Gender Specific Hepatitis D Prevalence
4.9.4. Age Specific Hepatitis D Prevalence
4.9.5. Diagnosed cases of Chronic Hepatitis D
5. Appendix
6. Report Methodology
6.1. Sources Used
7. DelveInsight Capabilities
8. Disclaimer
9. About DelveInsight
Table 1: 8MM, Historical & Forecasted Hepatitis D Prevalence, 2016-2027
Table 2: The United States, Historical & Forecasted Hepatitis D Prevalence, 2016-2027
Table 3: The United States, Historical & Forecasted Prevalence of Hepatitis D by severity, 2016-2027
Table 4: The United States, Gender-Specific Hepatitis D Prevalence, 2016-2027
Table 5: The United States, Age-Specific Hepatitis D Prevalence, 2016-2027
Table 6: The United States, Diagnosed cases of Hepatitis D, 2016-2027
Table 7: EU5, Historical & Forecasted Hepatitis D Prevalence, 2016-2027
Table 8: France, Historical & Forecasted Hepatitis D Prevalence, 2016-2027
Table 9: France, Historical & Forecasted Prevalence of Hepatitis D by severity, 2016-2027
Table 10: France, Gender Specific Hepatitis D Prevalence, 2016-2027
Table 11: France, Age Specific Hepatitis D Prevalence, 2016-2027
Table 12: France, Diagnosed cases of Hepatitis D, 2016-2027
Table 13: Germany, Historical & Forecasted Hepatitis D Prevalence, 2016-2027
Table 14: Germany, Historical & Forecasted Prevalence of Hepatitis D by severity, 2016-2027
Table 15: Germany, Gender-Specific Hepatitis D Prevalence, 2016-2027
Table 16: Germany, Age-Specific Hepatitis D Prevalence, 2016-2027
Table 17: Germany, Diagnosed cases of Hepatitis D, 2016-2027
Table 18: Italy, Historical & Forecasted Hepatitis D Prevalence, 2016-2027
Table 19: Italy, Historical & Forecasted Prevalence of Hepatitis D by severity, 2016-2027
Table 20: Italy, Gender-Specific Hepatitis D Prevalence, 2016-2027
Table 21: Italy, Age-Specific Hepatitis D Prevalence, 2016-2027
Table 22: Italy, Diagnosed cases of Hepatitis D, 2016-2027
Table 23: Spain, Historical & Forecasted Hepatitis D Prevalence, 2016-2027
Table 24: Spain, Historical & Forecasted Prevalence of Hepatitis D by severity, 2016-2027
Table 25: Spain, Gender Specific Hepatitis D Prevalence, 2016-2027
Table 26: Spain, Age Specific Hepatitis D Prevalence, 2016-2027
Table 27: Spain, Diagnosed cases of Hepatitis D, 2016-2027
Table 28: The United Kingdom, Historical & Forecasted Hepatitis D Prevalence, 2016-2027
Table 29: The United Kingdom, Historical & Forecasted Prevalence of Hepatitis D by severity, 2016-2027
Table 30: The United Kingdom, Gender Specific Hepatitis D Prevalence, 2016-2027
Table 31: The United Kingdom, Age-Specific Hepatitis D Prevalence, 2016-2027
Table 32: The United Kingdom, Diagnosed cases of Hepatitis D, 2016-2027
Table 33: Japan, Historical & Forecasted Hepatitis D Prevalence, 2016-2027
Table 34: Japan, Historical & Forecasted Prevalence of Hepatitis D by severity, 2016-2027
Table 35: Japan, Gender Specific Hepatitis D Prevalence, 2016-2027
Table 36: Japan, Age Specific Hepatitis D Prevalence, 2016-2027
Table 37: Japan, Diagnosed cases of Hepatitis D, 2016-2027
Table 38: China, Historical & Forecasted Hepatitis D Prevalence, 2016-2027
Table 39: China, Historical & Forecasted Prevalence of Hepatitis D by severity, 2016-2027
Table 40: China, Gender Specific Hepatitis D Prevalence, 2016-2027
Table 41: China, Age Specific Hepatitis D Prevalence, 2016-2027
Table 42: China, Diagnosed cases of Hepatitis D, 2016-2027

Get Free Sample

You can get a FREE sample of any report. Just click the "Free Sample" link.

Explore Latest Reports

If you have any special requirement or looking for more discounts, Kindly contact our sales team

Contact Us